These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 825589)
1. Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic. Lode H; Grunert K; Koeppe P; Langmaack H J Infect Dis; 1976 Nov; 134 SUPPL():S316-22. PubMed ID: 825589 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic]. Lode H; Grunert K; Koeppe P; Langmaack H Dtsch Med Wochenschr; 1976 Sep; 101(36):1312-7. PubMed ID: 782811 [TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli. Mathias RG; Ronald AR; Gurwith MJ; McCullough DW; Stiver HG; Berger J; Cates CY; Fox LM; Lank BA J Infect Dis; 1976 Nov; 134 SUPPL():S394-401. PubMed ID: 825590 [TBL] [Abstract][Full Text] [Related]
4. Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents. Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC J Infect Dis; 1976 Nov; 134 SUPPL():S381-3. PubMed ID: 993631 [TBL] [Abstract][Full Text] [Related]
5. Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies. Mazzei T; Paradiso M; Nicoletti I; Periti P J Infect Dis; 1976 Nov; 134 SUPPL():S374-9. PubMed ID: 993629 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience with amikacin, a new aminoglycoside antibiotic. Theron FP; De Kock MA S Afr Med J; 1977 May; 51(21):746-8. PubMed ID: 327583 [TBL] [Abstract][Full Text] [Related]
8. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy. Leonard JM; McGee ZA; Alford RH Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674 [TBL] [Abstract][Full Text] [Related]
10. Use of Amikacin in a hospital for children: microbiological and clinical studies. Marget W; Reindke B; Versmold H J Infect Dis; 1976 Nov; 134 SUPPL():S412-9. PubMed ID: 825592 [TBL] [Abstract][Full Text] [Related]
11. A review of results of clinical trials with amikacin. Gooding PG; Berman E; Lane AZ; Agre K J Infect Dis; 1976 Nov; 134 SUPPL():S441-5. PubMed ID: 792360 [TBL] [Abstract][Full Text] [Related]
12. Amikacin in the treatment of gram-negative bronchopulmonary infections. Van Der Straeten M; Pauwels R; Pijck J; Van Nimmen L; Kluyskens P; Soep H J Infect Dis; 1976 Nov; 134 SUPPL():S391-3. PubMed ID: 1086876 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of amikacin and kanamycin. Kirby WM; Clarke JT; Libke RD; Regamey C J Infect Dis; 1976 Nov; 134 SUPPL():S312-5. PubMed ID: 993624 [TBL] [Abstract][Full Text] [Related]
14. Amikacin therapy of infections in neutropenic patients. Valdivieso M; Feld R; Rodriguez V; Bodey GP Am J Med Sci; 1975; 270(3):453-63. PubMed ID: 1108649 [TBL] [Abstract][Full Text] [Related]
15. Serum concentrations and inhibitory ratios during amikacin therapy of gram-negative infections. Farchione LA; Chudzik GM J Clin Pharmacol; 1978; 18(8-9):432-8. PubMed ID: 690253 [TBL] [Abstract][Full Text] [Related]
16. Amikacin therapy for serious gram-negative bacillary infections. Meyer RD; Lewis RP; Carmalt ED; Finegold SM Ann Intern Med; 1975 Dec; 83(6):790-800. PubMed ID: 1200524 [TBL] [Abstract][Full Text] [Related]